Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

Caitlin E. Cox

December 24, 2019

News Conference News VIVA 2019

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

L.A. McKeown

November 08, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: Should Interventional Cardiologists Get Paid for Being On Call?

November 08, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Conference News TCT 2019

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Yael L. Maxwell

September 25, 2019

News Daily News

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Michael O'Riordan

August 28, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

News Daily News

Patients Retain Little From Cath Lab Informed-Consent Conversations

Michael O'Riordan

April 26, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News EHRA 2019

Tentative Link Found Between Solar Storms, New-Onset A-fib

Todd Neale

March 20, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

Advertisement

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel

Conversations in Cardiology: Should Interventional Cardiologists Get Paid for Being On Call?

Repeat Target-Lesion PCI: An Option for Public Reporting?

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

Patients Retain Little From Cath Lab Informed-Consent Conversations

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Time and Money: PCI Public Reporting Requirements Take Their Toll

Tentative Link Found Between Solar Storms, New-Onset A-fib

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content